GlassScriptPhysician profile
Robert L Kalb
NPI 1659377497
$17,449.10
in general payments reported to CMS, 2019-2025
37 companies · $2,575 in 2025
The $2,575 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,081 · 2020: $5,153 · 2021: $270 · 2022: $2,140 · 2023: $3,086 · 2024: $143 · 2025: $2,575.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,415 · Consulting Fee: $1,250 · Food and Beverage: $1,140.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,415.07 |
| Consulting Fee | $1,250.00 |
| Food and Beverage | $1,139.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,953.88 | 2019-2024 | Variax, Hoffmann, Core |
| Cdc Medical LLC | $2,596.00 | 2019-2022 | |
| Anika Therapeutics, INC. | $1,873.40 | 2022-2023 | Ovomotion |
| Moximed, INC | $1,401.94 | 2024-2025 | Misha Knee System, Small, Left |
| Wenzel Spine, INC. | $1,377.41 | 2022-2023 | Varilift |
| Vericel Corporation | $1,116.83 | 2025 | Maci |
| Amgen INC. | $732.12 | 2019-2022 | |
| Amniox Medical, INC. | $469.05 | 2019 | |
| 7d Surgical INC. | $309.82 | 2019 | |
| Biotissue Holdings INC. | $292.33 | 2019 | |
| Horizon Therapeutics Plc | $256.17 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $230.95 | 2019-2020 | |
| Fidia Pharma USA INC. | $201.94 | 2023 | Hymovis, Triluron |
| Zimmer Biomet Holdings, INC. | $179.67 | 2019-2024 | |
| Medacta USA, INC. | $171.30 | 2019-2022 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $158.58 | 2019 | |
| Conformis, INC. | $132.86 | 2019 | |
| US Implant Solutions, LLC | $126.37 | 2023 | |
| Teva Pharmaceuticals USA, INC. | $118.06 | 2019 | |
| Jazz Pharmaceuticals INC. | $99.88 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $98.65 | 2022 | |
| Medtronic, INC. | $95.52 | 2023 | Osteocool Rf Ablation System |
| E.R. Squibb & Sons, L.L.C. | $69.86 | 2019 | |
| Smith+Nephew, INC. | $67.55 | 2019-2020 | |
| Heron Therapeutics, INC. | $53.23 | 2025 | Zynrelef |
| Kowa Pharmaceuticals America, INC. | $44.89 | 2023 | Seglentis |
| Orthofix Medical, INC. | $35.25 | 2019 | |
| Acell, INC. | $30.05 | 2019 | |
| Pacira Therapeutics, INC. | $29.62 | 2021 | |
| Kci USA, INC. | $27.62 | 2021 | |
| Globus Medical, INC. | $20.32 | 2023 | Ankle Fracture System |
| Mimedx Group, INC. | $17.02 | 2025 | |
| Depuy Synthes Sales INC. | $16.74 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $16.31 | 2022 | |
| Acumed LLC | $14.67 | 2019 | |
| Radius Health, INC. | $13.24 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Kalb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.